AMPLITUDE

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) (AMPLITUDE). Click here to learn more.

C3441021 (TALAPRO2)

Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC. Click here to learn more.

PREVALENCE

A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer. Click here to learn more.


Learn more about Prostate Cancer >

Our Affiliations

 

 QCCA The Cancer FoundationNCI

We’re Here to Help! Click Below to Get Started

Contact Us Now